ASSESSING RESPONSE TO ANTI-CD20 THERAPY BY GENOTYPING C1Q COMPONENTS
摘要
<p>The present invention encompasses methods for predicting metastasis in cancer by assessing the structure of the complement protein C1qA. The methods may encompass examining either protein or nucleic acids, and may further include making treatment decisions based on the predictive methods.</p>
申请公布号
WO2007022374(A2)
申请公布日期
2007.02.22
申请号
WO2006US32173
申请日期
2006.08.17
申请人
THE UNIVERSITY OF IOWA RESEARCH FOUNDATION;RACILA, EMILIAN, V.;WEINER, GEORGE, J.
